Overweight Clinical Trial
Official title:
Eating Behavior in Adolescents
| Verified date | September 8, 2015 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study will explore the eating habits of adolescents and determine if eating behavior is
linked to genetics.
Healthy adolescents between 13 and 17 years of age may be eligible for this study. Candidates
come to the NIH Clinical Center at 8:00 AM to be screened with the following:
- Medical history and brief physical examination, including height, weight, and body fat
measurements. Body fat is measured using a device called a Bod Pod. The adolescent sits
inside the device for about 5 minutes and the machine determines body fat by measuring
air movement. The adolescent must wear a tight-fitting swimsuit for this test.
- Urine test to look for sugar or protein in the urine and to test for pregnancy in
females.
- Blood tests for routine chemistries and for gene studies related to eating behaviors.
- Questionnaires and interviews about the adolescent s general health and eating habits.
- Acclimatization to test meal conditions for the study. The adolescent is given a
breakfast shake to drink.
Participants come to the NIH Clinical Center at 10:30 AM for laboratory meal testing. At this
visit, the adolescent does the following:
- Eats food from a buffet of everyday foods that most kids eat.
- Fills out questionnaires.
- Tastes and rates the flavor of a variety of snack foods.
| Status | Completed |
| Enrollment | 301 |
| Est. completion date | September 8, 2015 |
| Est. primary completion date | |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 13 Years to 17 Years |
| Eligibility |
- INCLUSION CRITERIA: Volunteers will qualify for participation in the study if they meet the following criteria: 1. <TAB>Age 13-17 years. 2. <TAB>Good general health as indicated by medical history and physical examination. 3. <TAB>Negative urine glucose and normal electrolytes, hepatic, and thyroid function. 4. <TAB>For the fMRI portion only: right handedness (required for standardization of responses). 5. <TAB>For the fMRI portion only: female. 6. <TAB>For the fMRI portion only: overweight (BMI greater than or equal to 85th percentile for age and sex). EXCLUSION CRITERIA: Volunteers will be excluded if they have any of the following: 1. <TAB>Medical problem likely to affect caloric intake. 2. <TAB>History of any condition including psychiatric disorders in either child or their responsible parent that in the opinion of the investigators would impede competence to sign consent, interfere with adherence to procedures, or possibly hinder completion of the study. 3. <TAB>Pregnancy. 4. <TAB>Use of medication likely to affect caloric intake. 5. <TAB>History of significant neurological injury or insult. 6. <TAB>For the fMRI portion only: braces (or other metal) that would interfere with the fMRI procedure. 7. <TAB>For the fMRI portion only: non-native English speakers (required for standardization of responses). |
| Country | Name | City | State |
|---|---|---|---|
| United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Barros A. [Individual impression spoon from self polymerising plastics]. Zahnarztl Prax. 1967 Jan 1;18(1):1. German. — View Citation
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 Apr 5;295(13):1549-55. — View Citation
Taylor ED, Theim KR, Mirch MC, Ghorbani S, Tanofsky-Kraff M, Adler-Wailes DC, Brady S, Reynolds JC, Calis KA, Yanovski JA. Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006 Jun;117(6):2167-74. — View Citation
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |